|
PART
|
96T
|
48T
|
STORAGE
|
|
Pre-Coated Plate
|
8×12
|
8×6
|
4 ℃ / -20 ℃
|
|
Pre-Mixed Standards
|
2 vials
|
1 vial
|
4 ℃ / -20 ℃
|
|
Pre-Mixed Biotinylated Antibody (1:100)
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Enzyme Conjugate(1:100)
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Enzyme Diluent
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Antibody Diluent
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Standard Diluent
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Sample Diluent
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Washing Buffer (1:25)
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Color Reagent A
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Color Reagent B
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Color Reagent C
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Manual
|
1 set
|
1 set
|
RT
|
Place collected whole blood in refrigerator at 4 ℃ overnight. Then centrifuge for 10mins at 1000-3000 rpm. Take supernatant and either test immediately or place samples at -20 ℃/-80 ℃(1-3 months) for storage.
Take plasma where EDTA, sodium citrate, or heparin has been added as anticoagulant. Mix well. Centrifuge mixture for 10mins at 1000-3000 rpm. Take supernatant and test immediately or place samples at -20 ℃ /-80 ℃ (1-3 months) for storage.
Take tissue slices which have been washed in 0.01 M PBS and then a tissue protein extraction reagent has been added according to proportion of 1 g to 5-10 mL and then mixed on ice bath. After sufficient homogenization, please then centrifuge for 10mins at 5000-10000 rpm. Take supernatant for immediate testing, or place samples at -20 ℃/-80 ℃ (1-3 months) for storage.
Centrifuge for 10 mins at 1000-3000 rpm. Take supernatant for immediate testing, or place samples at -20 ℃/-80 ℃ (1-3 months) for storage.
Centrifuge for 10mins at 1000-3000 rpm. Take supernatant for immediate testing, or place samples at -20 ℃/-80 ℃ (1-3 months) for storage.
|
TYPICAL DATA
|
Reference STD1
|
Reference STD2
|
Reference STD3
|
Reference STD4
|
Reference STD5
|
Reference STD6
|
Reference STD7
|
Reference STD8
|
|
AsAb IgG, ng/mL
|
32
|
16
|
8
|
4
|
2
|
1
|
0.5
|
0
|
|
AsAb IgG, OD.
|
2.95
|
1.639
|
0.91
|
0.506
|
0.281
|
0.156
|
0.087
|
0.058
|
|
AsAb, ng/mL
|
32
|
16
|
8
|
4
|
2
|
1
|
0.5
|
0
|
|
AsAb, OD.
|
3.063
|
1.702
|
0.945
|
0.525
|
0.292
|
0.162
|
0.09
|
0.06
|
|
Anti-Ro, ng/mL
|
32
|
16
|
8
|
4
|
2
|
1
|
0.5
|
0
|
|
Anti-Ro, OD.
|
2.848
|
1.582
|
0.879
|
0.488
|
0.271
|
0.151
|
0.084
|
0.056
|
|
Anti-TA, ng/mL
|
32
|
16
|
8
|
4
|
2
|
1
|
0.5
|
0
|
|
Anti-TA, OD.
|
3.27
|
1.817
|
1.009
|
0.561
|
0.311
|
0.173
|
0.096
|
0.064
|
STANDARD CURVE
To assess linearity of the assay, samples were spiked with high concentrations of Human AsAb IgG, AsAb, Anti-Ro, Anti-TA and diluted with the appropriate calibrator diluent to produce samples with values within the dynamic range of the assay.
|
Matrix
|
Scope %
|
Average % Recovery Rate
|
|
serum(n=5)
|
83-94
|
88.5
|
|
EDTA plasma(n=5)
|
89-101
|
95
|
|
Cell Culture Media(n=5)
|
90-108
|
99
|
|
Within-Run Precision
|
Inter-Batch Precision
|
|||||
|
Sample
|
1
|
2
|
3
|
1
|
2
|
3
|
|
n
|
20
|
20
|
20
|
20
|
20
|
20
|
|
CV%
|
6
|
6.7
|
6.4
|
8.9
|
8.7
|
8.3
|